The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease-Reference-Cited by-同舟云学术

The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease

Published:2013-01 Issue:1 Volume:11 Page:96-106
ISSN:1541-4094
Container-title:FOCUS
language:en
Short-container-title:FOC

Author:

Albert Marilyn S.,DeKosky Steven T.,Dickson Dennis,Dubois Bruno,Feldman Howard H.,Fox Nick C.,Gamst Anthony,Holtzman David M.,Jagust William J.,Petersen Ronald C.,Snyder Peter J.,Carrillo Maria C.,Thies Bill,Phelps Creighton H.

Publisher

American Psychiatric Association Publishing

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Profile of the Italian Centers for Cognitive Disorders and Dementia in the Context of New Drugs in Alzheimer’s Disease;Journal of Alzheimer's Disease;2024-09-10

2. Effects of Supplementation with a Microalgae Extract from Phaeodactylum tricornutum Containing Fucoxanthin on Cognition and Markers of Health in Older Individuals with Perceptions of Cognitive Decline;Nutrients;2024-09-05

3. The Association Between Brain Metabolic Biomarkers Using 18F-FDG and Cognition and Vascular Risk Factors, as well as Its Usefulness in the Diagnosis and Staging of Alzheimer’s Disease;Journal of Alzheimer's Disease Reports;2024-09-05

4. The diagnostic value of plasma phosphorylated tau 181 in Alzheimer’s disease within the Chinese population: A systematic review and meta-analysis;2024-08-16

5. Biomarker-Based Precision Therapy for Alzheimer’s Disease: Multidimensional Evidence Leading a New Breakthrough in Personalized Medicine;Journal of Clinical Medicine;2024-08-08